Dr. Holmquist is on the Board of Advisors of the American Society of Pain Educators. Over the past decade, he has been invited to present over 1,000 CME and CE lectures on pain management across the country. He shares practical and relevant clinical information, with a touch of humor, ensuring that audiences not only listen but also hear an important message on managing pain and making a difference in the lives of their patients.
1. Discuss the burden of opioid misuse and abuse on the individual and society.
2. Differentiate addiction, physical dependency, tolerance and hyperalgesia.
3. Describe the similarities and differences in the mechanism of action for opioids, cannabinoids, and gabapentenoids.
4. Compare and contrast the role of opioids, cannabinoids, and gabapentenoids in: a) acute postoperative pain; b) chronic low back pain; c) neuropathic pain; d) chronic non-cancer pain; and , e) end-of-life pain crisis.
5. Identify typical characteristics of patients who would be identified as “high risk”, “moderate risk” and “low risk: for misusing, abusing or diverting opioids, and describe the best practice model for properly monitoring patients on opioids.
6. Describe how a provider should counsel patients who are started on opioids, gabapentenoids, and cannabinoids to minimize the risks of adverse reactions, over-dosage and inappropriate compliance.
7. Describe how pharmacists and other providers can improve patient and community safety with the use of opioids, gabapentenoids and cannabinoids.
8. Compare and contrast the most common cannabinoids found in marijuana with regards to their benefits and risks in managing pain and other symptoms.
9. Compare and contrast the benefits and risks of gabapentenoids in managing pain.
10. State the risks of combining opioids with: a) benzodiazepines; b) alcohol; c) gabapentenoids; and, d) cannabinoids.
11. Describe the role of naloxone in preventing deaths from overdosages.